Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1991 2
1993 1
1994 2
1995 5
1996 2
1997 4
1998 2
1999 8
2000 7
2001 6
2002 12
2003 16
2004 13
2005 22
2006 31
2007 33
2008 51
2009 46
2010 77
2011 91
2012 103
2013 122
2014 146
2015 169
2016 199
2017 176
2018 207
2019 247
2020 270
2021 301
2022 184
Text availability
Article attribute
Article type
Publication date

Search Results

2,253 results
Results by year
Filters applied: . Clear all
Page 1
An expanded universe of cancer targets.
Hahn WC, Bader JS, Braun TP, Califano A, Clemons PA, Druker BJ, Ewald AJ, Fu H, Jagu S, Kemp CJ, Kim W, Kuo CJ, McManus M, B Mills G, Mo X, Sahni N, Schreiber SL, Talamas JA, Tamayo P, Tyner JW, Wagner BK, Weiss WA, Gerhard DS; Cancer Target Discovery and Development Network. Hahn WC, et al. Among authors: mo x. Cell. 2021 Mar 4;184(5):1142-1155. doi: 10.1016/j.cell.2021.02.020. Cell. 2021. PMID: 33667368 Free PMC article. Review.
Multicenter assessment of shotgun metagenomics for pathogen detection.
Liu D, Zhou H, Xu T, Yang Q, Mo X, Shi D, Ai J, Zhang J, Tao Y, Wen D, Tong Y, Ren L, Zhang W, Xie S, Chen W, Xing W, Zhao J, Wu Y, Meng X, Ouyang C, Jiang Z, Liang Z, Tan H, Fang Y, Qin N, Guan Y, Gai W, Xu S, Wu W, Zhang W, Zhang C, Wang Y. Liu D, et al. Among authors: mo x. EBioMedicine. 2021 Dec;74:103649. doi: 10.1016/j.ebiom.2021.103649. Epub 2021 Nov 20. EBioMedicine. 2021. PMID: 34814051 Free PMC article.
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia.
Hu EY, Do P, Goswami S, Nunes J, Chiang CL, Elgamal S, Ventura AM, Cheney C, Zapolnik K, Williams E, Mani R, Frissora F, Mo X, Waldmeier L, Beerli RR, Peng H, Rader C, Long M, Grawunder U, Byrd JC, Muthusamy N. Hu EY, et al. Among authors: mo x. Blood Adv. 2021 Aug 24;5(16):3152-3162. doi: 10.1182/bloodadvances.2020003276. Blood Adv. 2021. PMID: 34424320 Free PMC article.
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.
Mo X, Niu Q, Ivanov AA, Tsang YH, Tang C, Shu C, Li Q, Qian K, Wahafu A, Doyle SP, Cicka D, Yang X, Fan D, Reyna MA, Cooper LAD, Moreno CS, Zhou W, Owonikoko TK, Lonial S, Khuri FR, Du Y, Ramalingam SS, Mills GB, Fu H. Mo X, et al. Cell. 2022 May 26;185(11):1974-1985.e12. doi: 10.1016/j.cell.2022.04.014. Epub 2022 May 4. Cell. 2022. PMID: 35512704
Perivascular cell-derived extracellular vesicles stimulate colorectal cancer revascularization after withdrawal of antiangiogenic drugs.
Huang M, Chen M, Qi M, Ye G, Pan J, Shi C, Yang Y, Zhao L, Mo X, Zhang Y, Li Y, Zhong J, Lu W, Li X, Zhang J, Lin J, Luo L, Liu T, Tang PM, Hong A, Cao Y, Ye W, Zhang D. Huang M, et al. Among authors: mo x. J Extracell Vesicles. 2021 May;10(7):e12096. doi: 10.1002/jev2.12096. Epub 2021 May 21. J Extracell Vesicles. 2021. PMID: 34035882 Free PMC article.
Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.
Niu X, Li S, Li P, Pan W, Wang Q, Feng Y, Mo X, Yan Q, Ye X, Luo J, Qu L, Weber D, Byrne-Steele ML, Wang Z, Yu F, Li F, Myers RM, Lotze MT, Zhong N, Han J, Chen L. Niu X, et al. Among authors: mo x. Front Immunol. 2020 Sep 30;11:582010. doi: 10.3389/fimmu.2020.582010. eCollection 2020. Front Immunol. 2020. PMID: 33117392 Free PMC article.
2,253 results